# Moderna vs Sanofi: valuation, size and margins compared

URL: https://funkfolio.com/compare/mrna-vs-sny

> Moderna and Sanofi side by side: market value, valuation, margins, balance sheet, one-year price change and superinvestor holders.

---

## Moderna vs Sanofi

Moderna (MRNA), health care, and Sanofi (SNY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Sanofi is worth $114.1B on the stock market and Moderna $83.7B: Sanofi is valued at 36% more. Moderna's operating margin in its latest fiscal year was -158% and Sanofi's 14.5%. Over the past year Moderna's share price has moved +764% and Sanofi's -4.48%.

### Key facts

- **Moderna market value:** $83.7B
- **Sanofi market value:** $114.1B
- **Sanofi P/E:** 23.6
- **Moderna revenue:** $1.9B FY to 2025-12-31
- **Sanofi revenue:** $48.4B FY to 2025-12-31
- **Superinvestors holding both:** 0

Market values as of 18 Nov 2026, 07:29 UTC.

Moderna vs Sanofi: every measure side by side

| Measure | Moderna | Sanofi |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | France |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $83.7B lower | $114.1B higher |
| Revenue | $1.9B lower | $48.4B higher |
| Earnings | -$2.8B lower | $8.7B higher |
| Employees | 4,700 lower | 74,846 higher |
| Total assets | $12.3B lower | $140.7B higher |
| Valuation |  |  |
| P/E | — | 23.6 |
| P/S | 43.0 higher | 2.4 lower |
| P/B | 12.2 | — |
| Dividend yield | 0.00% | — |
| Profitability |  |  |
| Operating margin | -158% lower | 14.5% higher |
| Balance sheet |  |  |
| Net assets | $8.7B lower | $79.2B higher |
| Total liabilities | $3.7B lower | $61.1B higher |
| Total debt | $590M lower | $20.8B higher |
| Cash on hand | $2.6B lower | $8.5B higher |
| Price change |  |  |
| Today | -3.93% lower | -1.78% higher |
| 1 year | +764% higher | -4.48% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Moderna 835.2, Sanofi 91.8.

- Moderna (MRNA)
- Sanofi (SNY)

Moderna and Sanofi share prices over one year, rebased to 100: Moderna ends at 835.2, Sanofi at 91.8.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | MRNA | SNY |
| --- | --- | --- |
| Nov 28, 2025 | 104.9 | 96.3 |
| Dec 31, 2025 | 119.1 | 93.6 |
| Jan 30, 2026 | 178.0 | 90.8 |
| Feb 27, 2026 | 216.4 | 94.0 |
| Mar 31, 2026 | 205.2 | 93.0 |
| Apr 30, 2026 | 185.5 | 90.0 |
| May 29, 2026 | 190.6 | 84.3 |
| Jun 30, 2026 | 282.8 | 82.4 |
| Jul 31, 2026 | 221.4 | 83.2 |
| Aug 31, 2026 | 566.8 | 85.7 |
| Sep 30, 2026 | 777.7 | 79.6 |
| Oct 30, 2026 | 895.5 | 85.6 |
| Nov 17, 2026 | 835.2 | 91.8 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (0)

None of the tracked investors.

#### Moderna only (2)

- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 2.1%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.4%

#### Sanofi only (7)

- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 1.2%
- [Louis Bacon](https://funkfolio.com/gurus/louis-bacon) 0.5%
- [Sarah Ketterer](https://funkfolio.com/gurus/sarah-ketterer) 0.4%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 0.3%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.1%
- [Lee Ainslie](https://funkfolio.com/gurus/lee-ainslie) &lt;0.1%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio. [Who owns MRNA](https://funkfolio.com/stock/MRNA/superinvestors) · [Who owns SNY](https://funkfolio.com/stock/SNY/superinvestors)

### More on Moderna

- [Moderna (MRNA) stock page](https://funkfolio.com/stock/MRNA)
- [Moderna market cap](https://funkfolio.com/stock/MRNA/market-cap)
- [Moderna revenue](https://funkfolio.com/stock/MRNA/revenue)
- [Moderna P/E ratio](https://funkfolio.com/stock/MRNA/pe-ratio)
- [Moderna operating margin](https://funkfolio.com/stock/MRNA/operating-margin)
- [Moderna total debt](https://funkfolio.com/stock/MRNA/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Sanofi

- [Sanofi (SNY) stock page](https://funkfolio.com/stock/SNY)
- [Sanofi market cap](https://funkfolio.com/stock/SNY/market-cap)
- [Sanofi revenue](https://funkfolio.com/stock/SNY/revenue)
- [Sanofi P/E ratio](https://funkfolio.com/stock/SNY/pe-ratio)
- [Sanofi operating margin](https://funkfolio.com/stock/SNY/operating-margin)
- [Sanofi total debt](https://funkfolio.com/stock/SNY/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Moderna against its closest peers

- [Moderna vs CVS Health](https://funkfolio.com/compare/cvs-vs-mrna)
- [Moderna vs HCA Healthcare](https://funkfolio.com/compare/hca-vs-mrna)
- [Moderna vs GSK](https://funkfolio.com/compare/gsk-vs-mrna)

#### Sanofi against its closest peers

- [Sanofi vs McKesson](https://funkfolio.com/compare/mck-vs-sny)
- [Sanofi vs CVS Health](https://funkfolio.com/compare/cvs-vs-sny)
- [Sanofi vs Stryker](https://funkfolio.com/compare/sny-vs-syk)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Moderna or Sanofi?**

By market value, Sanofi is the larger: $114.1B against $83.7B for Moderna. By revenue in its latest fiscal year, Sanofi is the larger: $48.4B against $1.9B for Moderna.

**Which has the higher operating margin?**

Sanofi: 14.5%, against -158% for Moderna. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has more debt?**

Sanofi: $20.8B, against $590M for Moderna. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Moderna and Sanofi?**

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold Moderna and 7 hold Sanofi.

### Cite this page

Funkfolio, “Moderna vs Sanofi”, data as of 18 November 2026. https://funkfolio.com/compare/mrna-vs-sny

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
